Objective: Aberrant immune responses have been identified in obesity; however, immune cells of lymph nodes residing in the inflammatory environment of visceral adipose tissue have been largely overlooked. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can reduce inflammation and modify T-cell function and therefore may improve immune function in obesity. Thus, we determined the effects of feeding fish oil (FO) containing EPA and DHA on mesenteric lymph node (MLN) immune cell function. Methods: In this study, 14-week-old obese, leptin receptor-deficient JCR:LA-cp rats (cp/cp) (n ¼ 10 per group) were randomized to one of three nutritionally adequate diets for 3 weeks: control (ctl, 0% EPA þ DHA), low FO (LFO, 0.8% w/w EPA þ DHA) or high FO (HFO, 1.4% w/w EPA þ DHA). Lean JCR:LA-cp (Cp/cp or Cp/Cp) rats (n ¼ 5) were fed ctl diet. MLN cell phospholipid (PL) fatty acid composition, phenotypes and cytokine production were measured. Results: Obese ctl rats produced more IL-1b, IL-4 and IL-10, despite a higher proportion of (nÀ3) polyunsaturated fatty acids (PUFAs) and a lower (nÀ6):(nÀ3) PUFA ratio in MLN PL compared with lean ctl rats (Po0.05). Concanavalin A-stimulated IL-2 production did not differ from lean rats even though obese ctl rats had a lower proportion of CD4 þ CD25 þ cells (Po0.05). Feeding FO to obese rats increased the incorporation of (nÀ3) PUFA into MLN PL and normalized production of IL-1b (HFO only), IL-4 and IL-10 to the levels similar to lean ctl rats (Po0.05). Conclusion: We demonstrate for the first time that obese JCR:LA-cp rats have impaired responses of MLN immune cells to mitogen stimulation and altered PL fatty acid composition. Feeding FO lowered the ex vivo inflammatory response (HFO only) and production of Th2 cytokines, without changing IL-2 production from ConA-stimulated splenocytes, which may occur independent of leptin signalling.
Introduction
It is well established that higher levels of circulating biomarkers of inflammation are present in the obese/ insulin-resistant state, strongly suggesting inappropriate immune activation or regulation (as reviewed by Gil et al. ). Moreover, individuals with a higher body mass index are reported to be at an increased risk of infection and infection-related mortality (as reviewed by Falagas and Kompoti 2 ), have poor antibody responses to vaccines [3] [4] [5] and have immune cells with a reduced capacity to proliferate when stimulated with T-cell mitogens. 6, 7 More recently, a higher prevalence of atopic diseases has been reported in the overweight population, suggesting heightened activation of T-helper 2 (Th2) cells (as reviewed by Hersoug and Linneberg 8 ). Adipose tissue has been shown to be actively involved in producing and secreting inflammatory mediators, including leptin, adiponectin, monocyte chemoattractant protein-1, IL-6 and tumor necrosis factor-a. 1 However, the impact of visceral adipose tissue accretion on more specific aspects of immune function is not well defined. ). Only one study has investigated mesenteric lymph node (MLN) immune cell function in an obese rodent. Kim et al. 11 reported atrophy of MLN, and a fewer total number of lymphocytes were present in MLN in high fat-fed mice. Collectively, research suggests an effect of obesity/visceral fat on immune cells located in MLN and vice versa; however, the ability of these immune cells to respond to stimulation has not been assessed. The JCR:LA-cp rat is a genetic model of obesity that expresses a non-functional leptin receptor that prevents any known signal transduction of leptin. Rats that are homozygous for the autosomal recessive cp gene (cp/cp) are obese and insulin resistant, have dyslipidaemia and develop early atherosclerotic lesions. [12] [13] [14] Consequently, this model has been used extensively to study the impact of metabolic syndrome on various parameters of cardiovascular disease; 15, 16 however, this is the first study to examine aspects of the gut-associated immune system. It is well established that dietary nutrients, particularly lipids, can influence T-cell function and the inflammatory response. The (n-3) polyunsaturated fatty acids (PUFA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been of particular focus due to their beneficial effects on immunity and inflammation in other chronic inflammatory conditions (as reviewed by Calder 17 ). Furthermore, there is sufficient evidence to suggest that (n-3) PUFA can modify visceral adipose tissue by improving the inflammatory environment and decreasing adiposity. [18] [19] [20] Other researchers have reported that feeding a diet enriched in EPA and DHA to macrosomic pups of diabetic dams improved the proliferative response of splenocytes to concanavalin A (ConA) and lowered the Th1:Th2 of serum cytokines. 21, 22 These studies suggest that feeding fish oil (FO) to obese rodents may lower the inflammatory reaction and improve T-cell proliferative responses in the spleen. Hence, the objectives of this study were to determine the influence of obesity on MLN immune cell function and to establish if a diet supplemented with long-chain (n-3) PUFA could improve the immune dysfunction present in the gut-associated lymph nodes in the obese JCR:LA-cp rat through modifications to the membrane fatty acid composition of MLN immune cells.
Methods
All animal care and experimental protocols were conducted in accordance with the Canadian Council on Animal Care and approved by the University of Alberta Animal Ethics Committee. Male obese (cp/cp) and lean (Cp/Cp or Cp/cp) rats of the JCR:LA-cp strain were raised in our breeding colony at the University of Alberta. All animals were individually housed in a temperature and humidity controlled environment with a 12/12-h reversed light cycle.
Animals were weaned at 3 weeks of age and given free access to water and standard laboratory rat chow (Lab diet 5001, PMI Nutrition International, Brentwood, MO, USA). At 12 weeks of age, 1% w/w cholesterol (Sigma, Oakville, ON, Canada) was added to the rat chow for 2 weeks to accelerate the atherosclerotic process. At 14 weeks, these rats were randomly allocated to receive one of the following nutritionally complete diets (n ¼ 10 per diet): control (Ctl, 0% EPA þ DHA, 1% w/w cholesterol), low FO (LFO, 0.8% w/w EPA þ DHA, 1%w/w cholesterol) or high FO (HFO, 1.4% w/w EPA þ DHA, 1% w/w cholesterol). Lean JCR:LA-cp (Cp/cp or Cp/Cp) rats (n ¼ 5) were fed the Ctl diet. As reported previously, the nutrient composition was identical among all diets except FO was added to the LFO and HFO diets. 23 The fat was composed of a mixture of flaxseed oil, sunflower oil and completely hydrogenated soybean oil, and FO was added to the LFO and HFO diets. The fatty acid composition of the dietary fats is described in Table 1 . Diets were prepared weekly and stored at 4 1C until fed; feed cups were replaced every 2-3 days to prevent oxidation. Animals were weighed and feed consumption, adjusted for food spillage, was recorded twice weekly. After an overnight fast, rats were killed by cardiac exsanguination under iso-fluorane anaesthesia. MLN were removed aseptically.
Isolation of MLN cells and primary culture conditions
The MLN were placed in sterile 0.5% w/v bovine serum albumin in Krebs-Ringer HEPES buffer (pH 7.4) and immune cells were isolated as we have previously described in detail. 24 Isolated MLN immune cells were resuspended in Abbreviations: Ctl, control; LFO, low fish oil; DHA, docosahexaenoic acid (22:6(n-3)); EPA, eicosapentaenoic acid (20:5(n-3)); HFO, high fish oil; MUFA, sum of monounsaturated fatty acids; ND, not detectable; (n-6) PUFA, sum of (n-6) polyunsaturated fatty acids; (n-3) PUFA, sum of (n-3) polyunsaturated fatty acids; SFA, sum of saturated fatty acids. , Sigma-Aldrich, Oakville, ON, Canada). After 48 h of culture, the supernatant was removed and stored at À80 1C until cytokine assays were performed. Cell pellets were washed with phosphate-buffered saline, re-pelleted and liquid was removed before storing at À80 1C for fatty acid analysis.
Phenotype analysis
The MLN immune cell subsets were identified by one, two or three colour direct immunofluorescence assay, as we have previously described. 25 The following pre-labelled monoclonal antibodies were used: CD3 and CD28 (FITC-labelled); CD4, CD8, CD3, CD11b/c and OX12 (PE-labelled); and CD25 and CD8 (biotin-labelled). All antibodies were purchased from BD Biosciences, PharMingen (Mississauga, ON, Canada) except CD4, and OX12, which were purchased from Serotec (Cedarlane Laboratories Ltd, Hornby, ON, Canada). Streptavidin-Quantum Red (R-PE-Cy5 fluorochrome, SigmaAldrich) was added to wells containing biotin-labelled antibody. Cell fixative (200 ml of 1% w/v paraformaldehyde) was added to each well after final wash. The proportion of cells that was positive for each marker was determined by flow cytometry (FACScan; Becton Dickinson, Sunnyvale, CA, USA) according to the relative fluorescence intensity using CellQuest software (Becton Dickinson).
Cytokine production and serum haptoglobin All of the following assays were performed according to the manufacturer's instructions. The cultured cell supernatants of unstimulated, ConA and PWM-stimulated MLN cells were used to determine IL-1b (detection limit: 31.2-2000 pg ml
À1
), IL-2 (23.4-1500 pg ml À1 ), IL-4 (1.6-100 pg ml
), IL-6 (78-5000 pg ml À1 ), IL-10 (15.6-1000 pg ml
) and interferon-g (31.25-2000 pg ml
) levels with OptEIA anti-rat enzyme-linked immunoabsorbant assay (BD Biosciences, PharMingen). Values below the range of detection were assigned half of the value of the lowest standard value. Serum haptoglobin levels were determined by a colorimetric assay purchased from Tri-Delta Development Limited (Maynooth, Ireland) according to the manufacturer's instructions. All samples were measured in duplicate and the absorbance for cytokine assays was measured at 450 and 630 nM for haptoglobin on a microtitre plate reader (SPECTRAmax 190, Molecular Devices, Sunnyvale, CA, USA). The coefficient of variance was p10% for all assays and the average of the duplicate data was used for statistical analysis.
MLN phospholipid fatty acid composition
A modified Folch method was used to extract lipids from isolated MLN cells 26 and total phospholipids (PLs) were isolated from whole cells on silica G plates. 27 Fatty acid methyl esters were prepared from total PLs 26 and were separated by automated gas liquid chromatography (Varian 3800, Varian Inc., Mississauga, ON, Canada) using a 100 m CP-Sil 88 fused capillary column (Varian Inc.) as described elsewhere.
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Statistics Statistical analysis was conducted using the SAS software statistical package (Version 9.1, SAS Institute, Cary, NC, USA). All data were reported as mean ± s.e.m. Significant differences among groups were determined by one-way analysis of variance procedures, and significant differences between groups were identified using the Duncan's multiple range test (Po0.05). All values were tested for normal distribution, and nonparametric data were log-transformed before statistical analyses. Differences among groups with data that remained nonparametric after log-transforming were analysed using Kruskal-Wallis test (Po0.05).
Results

Feed intake and body weight
Obese rats fed with the Ctl diet had higher daily feed intake (33 ± 0.4 vs 20 ± 0.3 g day
À1
, Po0.05) and final body weights (592 ± 5 vs 378 ± 4 g, Po0.05) compared with lean rats. Obese rats fed with LFO (556±16 g) or HFO (561±6 g) diet had lower final body weights than the obese rats fed with the Ctl diet (592 ± 5 g, Po0.05), but average daily feed intake did not differ (34±0.6 , LFO or 32±0.3 g day À1 , HFO).
Phospholipid fatty acid composition of MLN cells
The relative proportions of fatty acids from 14:0 to 24:1 (n-9) in MLN PLs are reported in Table 2 . Compared with lean rats, obese rats fed the Ctl diet had a higher proportion of C16:0, C16:1trans9, C16:1(n-7), C18:1(n-7), C20:3(n-6), C20:4(n-3), 22:1(n-9), C20:5(n-3), C22:3(n-3), C22:5(n-6), C22:6(n-3) and total monounsaturated fatty acid and total n-3 PUFA and a lower proportion of C18:0, C20:2(n-6), C20:4(n-6), C24:1 (n-9) and total n-6 PUFA and (n-6):(n-3) PUFA ratio (Po0.05).
Compared to Ctl-fed obese rats, obese rats fed either FO diet had a higher proportion of C18:0, C18:1(n-9), C18:2 (n-6), C20:5(n-3), C22:5(n-6), and total (n-3) PUFA and had a Fish oil and MLN cells and obese rats MR Ruth et al lower proportion of C20:2(n-6), C20:4(n-6), C24:1(n-9), total PUFA, PUFA/sum of saturated fatty acids ratio, (n-6) PUFA and n-6:n-3 ratio (Po0.05). Only obese rats fed with the HFO diet had significantly higher proportions of C16:0, C16:1 (n-9), C18:1(n-7), C22:6(n-3) and lower proportions of C20:2(n-6), C20:4(n-3) and C22:3(n-3) in comparison with obese rats fed with the Ctl diet (Po0.05). Compared to the LFO group, HFO rats had a greater proportion of C16:1(n-9), C18:1(n-7), C20:5(n-3), C22:5(n-3), total (n-3) PUFA and a smaller proportion of C20:4(n-3), C20:4(n-6), C24:1(n-9) and total (n-6) PUFA and (n-6):(n-3) PUFA ratio (Po0.05).
Phenotypes of MLN immune cells
Obese rats fed with the Ctl diet had a higher proportion of MLN cells that were CD3 þ CD8 þ (cytotoxic T cells), and 
Cytokine production of MLN immune cells
Obese rats fed with the Ctl diet produced more IL-1b, and IL-10 when MLN immune cells were stimulated with PWM and more IL-4 when stimulated with ConA compared with lean rats fed with the same diet (Table 4) . Obese rats fed with either the LFO or HFO diet had lower ConA-stimulated IL-4 production compared with obese rats fed with the Ctl diet. However, only obese rats fed with the LFO diet had lower ConA-stimulated IL-10 production and only obese rats fed with the HFO diet had lower PWM-stimulated IL-1b. The production of IL-10 in unstimulated MLN immune cells did Abbreviations: Ctl, control; LFO, low fish oil; DHA, docosahexaenoic acid (22:6(n-3)); EPA, eicosapentaenoic acid (20:5(n-3)); HFO, high fish oil; MLN, mesenteric lymph node; MUFA, sum of monounsaturated fatty acids; ND, not detectable; (n-6) PUFA, sum of (n-6) polyunsaturated fatty acids; (n-3) PUFA, sum of (n-3) polyunsaturated fatty acids; SFA, sum of saturated fatty acids. Data represent mean±s.e.m.; n ¼ 9 per group for LFO, n ¼ 8 per group for obese Ctl and HFO and n ¼ 4 per group for lean rats. Differences among groups were determined by a one-way analysis of variance. Means within the same row that do not share a common letter are significantly different (Po0.05) as determined by Duncan's multiple range test. The relative proportions of fatty acids from 12:0 to 24:1(n-9) were measured in MLN phospholipid membrane, but only the major fatty acids were reported. , n ¼ 35). There were no detectable levels of IL-2, interferon-g, IL-4 or IL-6 in the supernatant of unstimulated MLN immune cells.
Haptoglobin Serum concentrations of haptoglobin were higher in obese Ctl rats (1.7 ± 0.1 mg ml
À1
) compared with lean Ctl rats (0.84±0.11 mg ml À1 ) (Po0.05). The concentration of serum haptoglobin in either the LFO-fed rats (1.6±0.1 mg ml À1 ) or HFO-fed rats (1.6 ± 0.1 mg ml
) did not differ from obese Ctl rats (Po0.05).
Discussion
This is the first study to investigate the effect of diet and obesity on the MLN cells, part of gut-associated immunity, in an established rodent model of the metabolic syndrome. Our findings show that MLN of obese JCR:LA-cp rats have an increased Th2 cytokine (IL-4 and IL-10) response and produce higher levels of an inflammatory cytokine (IL-1b) after mitogen stimulation. Furthermore, feeding diets containing EPA and DHA normalized these responses to the levels similar to lean rats and decreased weight gain in the JCR:LA-cp rat, without affecting the proliferative response (IL-2 production) of lymphocytes to a T-cell mitogen.
Fatty acid composition of splenocyte PLs
The fatty acid composition of MLN immune cell PL membranes in obese JCR:LA-cp rats differed significantly from lean rats fed with the same diet. Obese rats fed with the Ctl diet had a lower (n-6):(n-3) PUFA ratio due to a greater incorporation of total (n-3) fatty acids, including EPA, docosapentaenoic acid and DHA, and a lower incorporation of total (n-6) PUFA, including arachidonic acid. The lower (n-6):(n-3) PUFA ratio in MLN PLs is consistent with our findings in splenocyte PLs of JCR:LA-cp and fa/fa Zucker rats. 23, 29 The literature is supportive that increasing dietary (n-3) PUFA lowers the (n-6):(n-3) PUFA ratio in the PL membrane of inflammatory immune cells and indicate that a lower amount of arachidonic acid is available for inflammatory eicosanoid production (as reviewed by Calder 17 ). Several studies conducted in chronic states of inflammation have reported that feeding FO lowers the production of inflammatory cytokines, including IL-1b. 30, 31 Furthermore, FO may also be beneficial in conditions with increased Th2 cytokine responses (as reviewed by Prescott and Calder 32 ). However, despite a lower (n-6):(n-3) PUFA ratio in MLN immune cell PLs in obese JCR:LA-cp rats, mitogen-stimulated production of an inflammatory cytokine and Th2 cytokines was still higher, suggesting that additional factors contribute to the cytokine response in this animal model. It is possible that the chronic inflammatory state, as evidenced by higher circulating haptoglobin in obese JCR:LA-cp rats, and/or the adipose tissue environment may partly explain the altered cytokine response of MLN immune cells in obese rats. Furthermore, this data suggest that the JCR:LA-cp rat has altered essential fatty acid metabolism.
Potential influence of adipose tissue on MLN immune cells
Recent evidence indicates that adipose tissue, particularly visceral fat, is actively involved in producing and secreting inflammatory mediators. 1 To date, only one study has investigated the impact of obesity on MLN immune cell function. Kim et al. 11 reported that high fat-fed mice had smaller MLN and subsequently fewer immune cells. The authors suggested that factors emanating from the mesenteric fat, such as free fatty acids, induced apoptosis of lymphocytes residing in MLN. 11 In this study, we also show that immunity in gut-associated lymph tissue is altered. More specifically, MLN immune cells of obese JCR:LA-cp rats produced higher amounts of IL-1b, suggesting a heightened inflammatory response as compared with peripheral immune cells and are most likely influenced by the inflammatory environment of the mesenteric adipose tissue. We previously reported no difference in IL-1b production of PWM-stimulated splenocytes from obese JCR:LA-cp rats. 23 Of the MLN cell types measured, there were no differences between lean and obese Ctl-fed rats that could account for the difference in IL-1b. This indicates that the higher production of IL-1b in obese JCR:LA-cp rats was most likely due to a functional change in MLN immune cells. Concanavalin A-stimulated IL-2 production did not differ between lean and obese JCR:LA-cp rats, indicating the T-cell function was not impaired. In contrast, lower T-cell mitogenstimulated proliferation and IL-2 production in splenocytes ).
Potential contribution of a leptin receptor defect Despite the lower (n-6):(n-3) PUFA ratio and absence of leptin signal through the long form of the leptin receptor (Ob-Rb), obese JCR:LA-cp rats produced more mitogenstimulated IL-1b and IL-2 production did not differ from lean rats. These findings were unexpected in the light of evidence that suggests leptin is critical for the proliferative response of CD4 þ T lymphocytes, prevention of T-lymphocyte apoptosis and secretion of IL-2, as well as regulation of the inflammatory response of both the innate and acquired immune systems (as reviewed by Matarese et al. 38 ). Our data imply that leptin signalling through the leptin receptor is not critical for adequate IL-2 or IL-1b secretion in mitogen-stimulated MLN immune cells in the obese JCR:LA-cp rat.
Effects of feeding FO on MLN immune cell function
Feeding FO to obese JCR:LA-cp rats could be interpreted as a favourable effect on IL-4 and IL-10 production and those rats fed the higher level of EPA and DHA produced less of an inflammatory cytokine (IL-1b). Although the effects of dietary (n-3) PUFA on immune function are limited, Khan et al. 22 reported contrary to our findings that overweight offspring fed a high (n-3) PUFA diet had lower mRNA levels of interferon-g in spleen and higher mRNA levels of IL-4. The apparent disparity between our study and Khan's may be due to the initial higher interferon-g and lower IL-4 mRNA spleen levels, the much lower dietary (n-3):(n-6) PUFA, the tissue examined and the younger age of the rodents studied in Kahn et al's study. 22 Similar to our study in which IL-4 production was elevated, it has been reported that feeding (n-3) PUFA can lower IL-4 levels, in a rodent model of contact dermatitis local. 39 Although the literature is inconsistent, there is some evidence that suggests dietary FO can lower serum IL-10 levels in a model of experimental rheumatoid arthritis, a state with high serum IL-10 40 and can lower IL-10 in response to allergen in susceptible neonates. 41 In this study, feeding FO did not significantly modify IL-2 production in MLN cells stimulated with a polyclonal T-cell mitogen (ConA), indicating that increasing dietary (n-3) PUFA does not suppress T-cell function in obese JCR:LA-cp rats, which has been reported in healthy animals. [42] [43] [44] [45] Overall, our study is supportive of the concept that FO may be beneficial in skewed Th2 states, as observed in the gut-associated lymph tissue of obese JCR:LA-cp rats.
The lower IL-1b production observed in immune cells of the MLN isolated from obese rats fed with the HFO diet is consistent with the lower (n-6):(n-3) PUFA ratio in MLN PLs. As stated previously, increasing the content of (n-3) PUFA in inflammatory cells can reduce the production of inflammatory mediators (as reviewed by Calder 17 ). Other effects of feeding (n-3) PUFA may have contributed to the lower inflammatory response of MLN immune cells, including decreased weight gain. In addition, recent studies have shown that feeding (n-3) PUFA can lower inflammatory mediator production of visceral adipose tissue, 18,20 which may have had an impact on the inflammatory response as observed in this study. Of the cell types examined (by flow cytometry), the HFO diet did not affect immune cell phenotypes that would explain the lower IL-1b production, suggesting that the higher level of (n-3) PUFA modifies functional aspects of MLN immune cells.
Conclusion
Our results show that mitogen-stimulated cytokine production from MLN immune cells is altered in the obese JCR: LA-cp rat, an established model of metabolic syndrome. Immune cells isolated from MLN of obese rats produced significantly more Th2 cytokines, IL-4 and IL-10, and an inflammatory cytokine, IL-1b, despite a higher proportion of (n-6):(n-3) PUFA in MLN PLs. These findings contrast our previous report on splenocyte function and suggest that MLN immune cells are influenced by the inflammatory environment of visceral adipose tissue. In comparison to lean rats, obese rats produced similar levels of IL-2 in response to a T-cell mitogen, even with a lower proportion of CD4 þ CD25 þ T cells. Feeding either the low or high FO diet had a favourable effect on body weight gain. Moreover, Fish oil and MLN cells and obese rats MR Ruth et al feeding FO to obese JCR:LA-cp rats normalized IL-4 and IL-10 production from MLN immune cells, without affecting ConA-stimulated IL-2 production. However, only the HFO diet significantly lowered IL-1b production, which indicates a higher level of EPA, and DHA may be required to improve the inflammatory response in obese rats. This is the first study to report that feeding FO to obese, leptin receptordeficient JCR:LA-cp rats normalizes impaired cytokine response of immune cells of MLNs residing in visceral adipose tissue. Moreover, these modifications are most likely mediated independent of leptin signalling.
